Core Points - The report details the fundraising and usage status of Matsui New Materials Group Co., Ltd. for the first half of 2025, confirming compliance with regulatory requirements and accurate disclosures [1][6][8] Fundraising Overview - The total amount raised from the public offering was RMB 686,152,000, with 1,990,000 shares issued at a price of RMB 34.48 per share [1][2] - After deducting underwriting and related fees totaling RMB 51,760,236.35, the net proceeds amounted to RMB 634,391,763.65, which was fully deposited into a designated account on June 2, 2020 [1][2] Fund Usage and Surplus - As of June 30, 2025, the company had invested RMB 407,116,710.56 into fundraising projects and used RMB 118,000,000 of over-raised funds to permanently supplement working capital [1][3] - The remaining balance of unused fundraising was RMB 149,295,240.96, with RMB 30,000,000 allocated to financial products [2][3] Fund Management - The company established a fundraising management system to ensure efficient use and protection of investor rights, including opening special accounts for fundraising [1][2] - A tripartite supervision agreement was signed with several banks and the underwriting institution to clarify responsibilities and obligations regarding the management of the funds [1][2] Cash Management - The company has utilized temporarily idle fundraising for cash management, with a maximum limit of RMB 580,000,000 approved for investment in low-risk financial products [2][3] - As of June 30, 2025, the balance of idle funds under cash management was RMB 30,000,000, invested in structured deposits [3][4] Use of Over-raised Funds - The company has used RMB 59,000,000 of over-raised funds for permanent working capital supplementation, approved by the board and shareholders [3][4] - The remaining over-raised funds were also allocated for similar purposes without affecting the funding needs of investment projects [4][7] Project Adjustments - The company has made adjustments to the investment amounts and timelines for certain fundraising projects to enhance efficiency and adapt to market conditions [4][7] - The total planned investment for adjusted projects increased by RMB 84,012,500, funded entirely by over-raised funds [4][7] Surplus Fund Usage - The company reported a surplus of RMB 91,724,400 as of December 31, 2024, due to cost savings from improved operational efficiencies and strategic procurement decisions [7][8] - The surplus funds will be allocated to new projects and permanent working capital, as approved by the board and shareholders [7][8]

证券代码：603916 证券简称：苏博特 公告编号：2025-044 转债代码：113650 转债简称：博 22 转债 江苏苏博特新材料股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 根据中国证券监督管理委员会《上市公司监管指引第 2 号——上市公司募 集资金管理和使用的监管要求》（证监会公告[2012]44 号）、上海证券交易所 发布的《上海证券交易所上市公司募集资金管理办法》及相关格式指引规定， 本公司将截止 2025 年 6 月 30 日募集资金存放与使用情况专项报告如下： 一、 募集资金基本情况 经中国证券监督管理委员会（以下简称"中国证监会"）证监许可[2022]1141 号文核准，公司于 2022 年 7 月 2 日公开发行了 800.00 万张可转换公司债券， 每张面值 100 元，发行总额 80,000 万元。经上海证券交易所自律监管决定书 [2022]196 号文同意，公司发行的 80,000.00 万元可转换公司债券于 2022 年 7 月 28 日在上海证券交易所挂牌交易。上述募集资金 ...

Core Points - Jiangsu Hongwei Technology Co., Ltd. reported on the status of its fundraising activities and the use of raised funds for the first half of 2025, ensuring compliance with relevant regulations [2][11]. Fundraising Overview - The company raised a total of RMB 677,387,918.34 from its initial public offering (IPO) by issuing 24,623,334 shares at a price of RMB 27.51 per share, with a net amount of RMB 596,804,289.33 after deducting issuance costs [2][3]. - The company also issued 4,300,000 convertible bonds at a price of RMB 100 each, raising RMB 43,000,000, with a net amount of RMB 42,327,690 after expenses [3]. Fund Usage and Balance - As of June 30, 2025, the remaining unused balance of the raised funds was RMB 1,766,075.01, all stored in designated accounts [6][11]. - The total amount used from the IPO funds was RMB 597,660,946.04, with an additional RMB 4,165.36 accrued from interest income [3][7]. - The company utilized RMB 11,000,000 from excess funds to permanently supplement working capital and RMB 6,000,000 from idle funds for temporary working capital [8][9]. Fund Management - The company has established a three-party supervision agreement with its underwriter and banks to ensure proper management and usage of the raised funds [4][11]. - The company has not engaged in any prior investment or replacement of the raised funds during the reporting period [7][10]. Compliance and Reporting - The company confirmed that it has adhered to all relevant regulations regarding the management and use of raised funds, with no violations or issues in disclosure [11].

Core Viewpoint - The document outlines the fundraising management system of Zhejiang Zhongxin Environmental Protection Technology Group Co., Ltd, emphasizing the importance of regulating the use and management of raised funds to protect investors' interests [1]. Fundraising Management - The company must establish internal control systems for the storage, use, and management of raised funds, ensuring clear regulations on storage, usage, changes, supervision, and accountability [1][2]. - The board of directors and senior management are responsible for ensuring the proper use of raised funds and must not participate in any unauthorized changes to the fund's purpose [2][3]. Fund Storage - Raised funds must be stored in a special account approved by the board of directors, and this account should not be used for non-fund purposes [7]. - A tripartite supervision agreement must be signed with the sponsor and the commercial bank within one month of the funds being received, detailing the management and oversight of the funds [8][9]. Fund Usage - The company must adhere to specific requirements when using raised funds, including clear application procedures, decision-making processes, and risk control measures [9][10]. - Funds should primarily be used for the company's main business, and any financial investments or loans to related parties are prohibited [10][11]. Idle Funds Management - Idle funds can be temporarily used for cash management, provided that the investments are safe and do not affect the normal investment plans [11][12]. - If idle funds are used to supplement working capital, it must be reported and approved by the board, and the funds must be returned to the special account within a specified timeframe [12][13]. Use of Excess Funds - Any excess funds raised beyond the planned amount must be allocated to ongoing or new projects, or for share buybacks, with a clear plan disclosed by the company [13][14]. - The use of excess funds requires board approval and must be disclosed to shareholders, ensuring transparency and accountability [14]. Fund Usage Change - Any changes to the use of raised funds must be approved by the board and the shareholders, with a clear explanation provided for the changes [18][19]. - The company must conduct feasibility analyses for new projects and ensure that they align with the main business objectives [19][20]. Fund Management and Supervision - The company is required to disclose the actual use of raised funds accurately and completely [23]. - The board must conduct semi-annual reviews of the fundraising projects and report on the status of fund usage [24][25]. Compliance and Reporting - Independent directors and the audit committee must monitor the management and usage of raised funds, and can engage external auditors for verification [25][26]. - The sponsor must conduct regular investigations into the management of raised funds and provide reports to the company and the stock exchange [26][27].

长城证券股份有限公司关于 浙江泰林生物技术股份有限公司 长城证券股份有限公司（以下简称"长城证券"或"保荐机构"）作为浙江泰林 生物技术股份有限公司（以下简称"泰林生物"或"公司"）首次公开发行股票并上 市持续督导保荐机构，根据《证券发行上市保荐业务管理办法》《深圳证券交易 所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创 业板上市公司规范运作（2025 年修订）》等有关规定，对公司 2025 年半年度募 集资金存放与使用情况进行了核查，具体情况如下： 一、募集资金基本情况 （一）实际募集资金金额、资金到位时间 经中国证券监督管理委员会《关于核准浙江泰林生物技术股份有限公司首次 公开发行股票的批复》（证监许可〔2019〕2962 号）核准，并经深圳证券交易 所同意，本公司由主承销商安信证券股份有限公司采用余额包销方式，向社会公 众公开发行人民币普通股（A 股）股票 1,300.00 万股，发行价为每股人民币 18.35 元，共计募集资金 23,855.00 万元，坐扣承销和保荐费用 2,545.00 万元后的募集 资金为 21,310.00 万元，已由主承销商安信证券股份有限公司于 ...

张 阳： 招商证券股份有限公司 募集资金承诺 调整后投资总 截至期末累计 资进度 预定可 使 本年度实现 达到 性是否发 和超募资金投 项目（含部 本期投入金额 投资总额 额（1） 投入金额(2) （%）(3)＝ 用状态日 的效益 预计 生重大变 向 分变更） (2)/(1) 期 效 益 化 年产 12000km 未 达 无机绝缘及年 到 预 无 268,360,000.00 268,360,000.00 127,090.00 265,079,147.85 98.78 - 18,569,621.05 否 产 600km 油井 计 效 加热电缆项目 益 补充流动资金 不 适 无 200,000,000.00 200,000,000.00 - 200,000,000.00 100.00 不适用 不适用 否 项目 用 超募资金永久 不 适 无 - 39,732,734.07 - 35,730,000.00 89.93 不适用 不适用 否 补充流动资金 用 承诺投资项目 - 468,360,000.00 508,092,734.07 127,090.00 500,809,147.85 98.57 - - - - 小计 ...

Core Points - The company held its 19th meeting of the 9th Board of Directors on August 27, 2025, where all 11 directors were present and the meeting complied with relevant laws and regulations [1] - The Board approved the 2025 semi-annual report and its summary, which had been previously reviewed by the Audit and Risk Prevention Committee [1] - The Board also approved a proposal to use up to 2 billion yuan of idle funds to purchase financial products, with the approval effective from the date of the meeting [2] - A special report on the use of raised funds for the first half of 2025 was also approved, in accordance with regulatory requirements [3] - The Board agreed to continue using up to 350 million yuan of temporarily idle raised funds for cash management, with the authorization for the chairman to make investment decisions [3][4]

Core Points - The company held its 13th meeting of the 4th Board of Directors on August 27, 2025, with all 7 directors present, complying with relevant laws and regulations [1][2]. Group 1: Meeting Resolutions - The board approved the 2025 semi-annual report and summary with a unanimous vote of 7 in favor [2]. - The board approved a special report on the storage and actual use of raised funds for the first half of 2025, also with a unanimous vote of 7 in favor [2]. - The board approved an adjustment to the repurchase price of the sixth phase of the restricted stock incentive plan and the repurchase and cancellation of certain restricted stocks, with a unanimous vote of 7 in favor [3]. - The board approved a proposal for a subsidiary to apply for listing on the New Third Board, with 6 votes in favor, 0 against, 0 abstentions, and 1 abstention due to conflict of interest [3][4]. - The board approved the establishment of a special account for raised funds and the signing of a regulatory agreement, with a unanimous vote of 7 in favor [4]. - The board approved the appointment of a new financial director, with a unanimous vote of 7 in favor [4]. - The board approved amendments to the Articles of Association and related governance documents, with a unanimous vote of 7 in favor, pending shareholder approval [5]. - The board approved the election of a non-independent director, with a unanimous vote of 7 in favor, pending shareholder approval [5]. - The board approved amendments to the Independent Director System, with a unanimous vote of 7 in favor, pending shareholder approval [5]. - The board approved amendments to the External Investment Management System, with a unanimous vote of 7 in favor, pending shareholder approval [6]. - The board approved amendments to the External Guarantee Management System, with a unanimous vote of 7 in favor, pending shareholder approval [6]. - The board approved amendments to the Related Party Transaction Management System, with a unanimous vote of 7 in favor, pending shareholder approval [6]. - The board approved amendments to the Internal Control System, with a unanimous vote of 7 in favor, pending shareholder approval [6]. - The board approved amendments to the Fund Management Measures, with a unanimous vote of 7 in favor, pending shareholder approval [8]. - The board approved a proposal to convene the third extraordinary general meeting of shareholders in 2025, with a unanimous vote of 7 in favor [8].

Group 1 - The core viewpoint of the announcement is that the Supervisory Board of Titan Technology has approved the 2025 semi-annual report and confirmed its compliance with relevant laws and regulations [1][2][3] - The meeting of the Supervisory Board was held on August 27, 2025, with all three supervisors present, ensuring the legality and validity of the resolutions made [1] - The Supervisory Board unanimously agreed that the semi-annual report accurately reflects the company's financial status and operational results for the first half of 2025 [2][3] Group 2 - The Supervisory Board confirmed that the management of raised funds complies with the relevant regulations and that there are no violations in the use of these funds [2][3] - The company plans to continue using up to RMB 400 million of idle funds from the 2021 A-share issuance for cash management in safe and liquid investment products, ensuring that this does not affect the ongoing investment projects [3][4] - The resolution regarding the use of idle funds was also unanimously approved by the Supervisory Board [4][5]

（安徽） 基地项目 补充流 动 不适 不适 否 400,000,000.00 400,000,000.00 400,000,000.00 - 400,912,344.51 912,344.51 100.23 不适 用 否 资 金 用 用 超募资 金 不适 不适 否 360,253,498.97 360,253,498.97 360,253,498.97 83,778,451.82 191,778,451.82 -168,475,047.15 不适用 不适 用 不适用 净 额 用 用 合计 — 1,266,253,498.97 1,266,253,498.97 1,266,253,498.97 116,781,932.01 685,050,523.09 -581,202,975.88 — — — — 未达到计划进度原因（分具体募投项目） 不适 用 项目可行性发生重大变化的情况说明 不适用 募集资金投资项目先期投入及置换情况 不适用 用闲置募集资金暂时补充流动资金情况 不适用 对闲置募集资金进行现金管理，投资相关产品情况 见本报告"三、募集资金的实际使用情况之 （四）对闲置募集资金进行现金管理，投资相关产品情况" ...